AMETEK Inc (AME, Financial) released its 8-K filing on February 4, 2025, announcing record financial results for the fourth quarter and full year ending December 31, 2024. The company reported a fourth-quarter sales record of $1.76 billion, marking a 2% increase from the previous year. Operating income rose by 5% to a record $469.0 million, with operating margins improving by 90 basis points to 26.6%. The company's GAAP earnings per diluted share reached a record $1.67, aligning with analyst estimates, while adjusted earnings per share were $1.87, surpassing expectations.
Founded in 1930, AMETEK Inc (AME, Financial) has evolved through the acquisition of numerous esteemed brands, establishing a portfolio of over 40 autonomous industrial businesses. Operating within the research, aerospace, energy, medical, and manufacturing industries, AMETEK segments its operations into two groups: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). EIG offers a wide range of analytical, test, and measurement instruments, while EMG provides highly engineered components, interconnects, and specialty metals. The company focuses on product differentiation and market leadership in niche markets.
AMETEK's performance in the fourth quarter and full year of 2024 underscores its operational flexibility and disciplined execution. The company's ability to navigate an uncertain macroeconomic environment has positioned it for continued long-term success. The Electronic Instruments Group (EIG) reported a slight decline in sales, down 2% to $1.21 billion, but achieved an 8% increase in operating income to a record $386.6 million, with operating margins reaching 31.8%. The Electromechanical Group (EMG) saw an 11% increase in sales to $546.7 million, driven by acquisitions and strong growth in Aerospace and Defense businesses.
AMETEK's financial achievements are significant for the industrial products industry. The company set annual records for sales, operating income, EBITDA, operating cash flow, free cash flow, and both GAAP and adjusted earnings per share. Full-year sales reached $6.94 billion, a 5% increase over 2023. Operating income for the year was $1.78 billion, representing 25.6% of sales, with earnings per diluted share at $5.93. Adjusted earnings per share for the year were $6.83, a 7% increase from the previous year.
AMETEK's financial statements reveal important metrics that highlight its robust performance. The company's operating cash flow for the fourth quarter was a record $550.0 million, with free cash flow at $498.3 million, achieving a 129% conversion rate from net income. These metrics are crucial for assessing the company's ability to generate cash and fund strategic initiatives.
Metric | Q4 2024 | Q4 2023 | Full Year 2024 | Full Year 2023 |
---|---|---|---|---|
Net Sales | $1.76 billion | $1.73 billion | $6.94 billion | $6.60 billion |
Operating Income | $469.0 million | $445.0 million | $1.78 billion | $1.71 billion |
GAAP EPS | $1.67 | $1.48 | $5.93 | $5.67 |
Adjusted EPS | $1.87 | $1.68 | $6.83 | $6.38 |
AMETEK's strong financial performance is a testament to its strategic growth model, which emphasizes operational excellence, technology innovation, global and market expansion, and strategic acquisitions. The company's focus on cash generation and capital deployment has enabled it to achieve double-digit percentage growth in earnings per share over the business cycle. Looking ahead, AMETEK is well-positioned to continue its growth trajectory, with expectations for low single-digit sales growth and adjusted earnings per share in the range of $7.02 to $7.18 for 2025.
“AMETEK delivered strong results in the fourth quarter, with outstanding operating performance driving robust core margin expansion, record earnings and strong cash flow growth,” stated David A. Zapico, AMETEK Chairman and Chief Executive Officer.
Explore the complete 8-K earnings release (here) from AMETEK Inc for further details.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。